These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18610759)

  • 1. [Can glitazones provide protection of the kidneys?].
    Bonnet F
    Journ Annu Diabetol Hotel Dieu; 2007; ():77-84. PubMed ID: 18610759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glitazones critically evaluated].
    Schernthaner G
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Too positive comment on glitazones].
    Lindberg M
    Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is there a need of glitazones in the treatment of diabetes?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2124; author reply 2124. PubMed ID: 17717584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glitazones--again].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2707; author reply 2707. PubMed ID: 17952161
    [No Abstract]   [Full Text] [Related]  

  • 6. [The true place of glitazones in the treatment of diabetes: after the PROactive study].
    Lindberg M; Jørgensen PH; Kampmann JP
    Ugeskr Laeger; 2006 Jun; 168(25):2477-9; author reply 2479-80. PubMed ID: 16824389
    [No Abstract]   [Full Text] [Related]  

  • 7. Which should we ADOPT: sulphonylureas or glitazones?
    Koshiyama H; Inagaki N; Seino Y
    Diabet Med; 2007 Jul; 24(7):804. PubMed ID: 17596243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glitazones in type 2 diabetes--documented risks, uncertain benefits].
    Håkansson J
    Lakartidningen; 2007 Oct 24-30; 104(43):3198-200. PubMed ID: 18018937
    [No Abstract]   [Full Text] [Related]  

  • 9. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glitazones more than hypoglycemics in type 2 diabetes].
    Sjöholm A
    Lakartidningen; 2007 Oct 24-30; 104(43):3201-3. PubMed ID: 18018938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
    Sarafidis PA; Bakris GL
    Kidney Int; 2006 Oct; 70(7):1223-33. PubMed ID: 16883325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROactive Study: (r)evolution in the therapy of diabetes?
    Ceriello A
    Diabet Med; 2005 Nov; 22(11):1463-4. PubMed ID: 16241907
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiazolidinediones: a novel class of drugs for the prevention of diabetic nephropathy?
    Zheng F; Guan Y
    Kidney Int; 2007 Dec; 72(11):1301-3. PubMed ID: 18004308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials.
    Charbonnel B
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():19-20. PubMed ID: 18001315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Don't judge all glitazones alike!].
    Sjöholm A
    Lakartidningen; 2007 Oct 24-30; 104(43):3205. PubMed ID: 18018940
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin sensitizer affects lipids.
    Health News; 2005 Jan; 11(1):2. PubMed ID: 15726701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heart failure while taking glitazones--what do we know today?].
    Halbritter R
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
    [No Abstract]   [Full Text] [Related]  

  • 20. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF; Lohray BB
    J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.